FAIR VALUE MEASUREMENTS (Details Textual) (USD $)	9 Months Ended	12 Months Ended		1 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2010 Manhattan and Ariston Pharmaceuticals Merger [Member]
Fair Value Measurement [Line Items]
Notes Issued				$ 15,452,793
Debt Instrument, Interest Rate, Effective Percentage	5.00%			5.00%
Debt Instrument, Convertible, Conversion Price				$ 1,125
Percentage Of Cash Proceeds From Operation To Repay Convertible Debt				50.00%
Long-term Debt, Gross	18,390,000	17,727,000	16,876,000
Debt Instrument, Fair Value Disclosure			$ 3,287,700
Fair Value Inputs, Discount Rate	20.00%	20.00%